{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T09:32:02Z","timestamp":1768383122354,"version":"3.49.0"},"reference-count":150,"publisher":"Aging and Disease","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging and disease"],"published-print":{"date-parts":[[2024]]},"DOI":"10.14336\/ad.2024.1298","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T17:36:52Z","timestamp":1733852212000},"page":"0","source":"Crossref","is-referenced-by-count":1,"title":["Multi-Omics Research on Angina Pectoris: A Novel Perspective"],"prefix":"10.14336","author":[{"given":"Haiyang","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiyan","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanwei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunpeng","family":"Chi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5462","reference":[{"key":"key-10.14336\/AD.2024.1298-1","doi-asserted-by":"crossref","unstructured":"Nanna MG, Wang SY, Damluji AA (2023). Management of Stable Angina in the Older Adult Population. Circ Cardiovasc Interv, 16:e012438.","DOI":"10.1161\/CIRCINTERVENTIONS.122.012438"},{"key":"key-10.14336\/AD.2024.1298-2","doi-asserted-by":"crossref","unstructured":"Smith SC Jr., Collins A, Ferrari R, Holmes DR, Jr., Logstrup S McGhie DV,et al. (2012). Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke). Circulation, 126:2769-75.","DOI":"10.1161\/CIR.0b013e318267e99f"},{"key":"key-10.14336\/AD.2024.1298-3","doi-asserted-by":"crossref","unstructured":"Ford TJ, Berry C (2020). Angina: contemporary diagnosis and management. Heart, 106:387-398.","DOI":"10.1136\/heartjnl-2018-314661"},{"key":"key-10.14336\/AD.2024.1298-4","doi-asserted-by":"crossref","unstructured":"Thuesen AL, Riber LP, Veien KT, Christiansen EH, Jensen SE, Modrau I, et al. (2021). Health-Related Quality of Life and Angina in Fractional Flow Reserve- Versus Angiography-Guided Coronary Artery Bypass Grafting: FARGO Trial (Fractional Flow Reserve Versus Angiography Randomization for Graft Optimization). Circ Cardiovasc Qual Outcomes, 14:e007302.","DOI":"10.1161\/CIRCOUTCOMES.120.007302"},{"key":"key-10.14336\/AD.2024.1298-5","doi-asserted-by":"crossref","unstructured":"Liao W, Ma X, Li J, Li X, Guo Z, Zhou S, et al. (2019). A review of the mechanism of action of Dantonic(\u00ae) for the treatment of chronic stable angina. Biomed Pharmacother, 109:690-700.","DOI":"10.1016\/j.biopha.2018.10.013"},{"key":"key-10.14336\/AD.2024.1298-6","doi-asserted-by":"crossref","unstructured":"Chen L, Yu YN, Liu J, Chen YY, Wang B, Qi YF, et al. (2022). Modular networks and genomic variation during progression from stable angina pectoris through ischemic cardiomyopathy to chronic heart failure. Mol Med, 28:140.","DOI":"10.1186\/s10020-022-00569-3"},{"key":"key-10.14336\/AD.2024.1298-7","doi-asserted-by":"crossref","unstructured":"Jin X, Yang S, Lu J, Li Y, Zhao Y, Li D, et al. (2022). Exploring the therapeutic mechanism of Baduanjin in the treatment of elderly stable angina pectoris based on the gut microbiota-lipid metabolism spectrum: Study protocol for a randomized controlled trial. Front Public Health, 10:1027839.","DOI":"10.3389\/fpubh.2022.1027839"},{"key":"key-10.14336\/AD.2024.1298-8","doi-asserted-by":"crossref","unstructured":"Liu Z, Liu J, Li Y, Wang H, Liang Z, Deng X, et al. (2021). VPS33B suppresses lung adenocarcinoma metastasis and chemoresistance to cisplatin. Genes Dis, 8:307-319.","DOI":"10.1016\/j.gendis.2019.12.009"},{"key":"key-10.14336\/AD.2024.1298-9","doi-asserted-by":"crossref","unstructured":"Man C, Dai Z, Fan Y (2020). Dazhu Hongjingtian Preparation as Adjuvant Therapy for Unstable Angina Pectoris: A Meta-Analysis of Randomized Controlled Trials. Front Pharmacol, 11:213.","DOI":"10.3389\/fphar.2020.00213"},{"key":"key-10.14336\/AD.2024.1298-10","doi-asserted-by":"crossref","unstructured":"Mohajeri M, Cicero AFG (2023). Adherence to the Mediterranean Diet Association with Serum Levels of Nitric Oxide, Prostacyclin, and Thromboxane B(2) among Prinzmetal Angina Patients and Healthy Persons. Nutrients, 15:","DOI":"10.3390\/nu15030738"},{"key":"key-10.14336\/AD.2024.1298-11","doi-asserted-by":"crossref","unstructured":"Taqueti VR (2019). Coronary Microvascular Dysfunction in Vasospastic Angina: Provocative Role for the Microcirculation in Macrovessel Disease Prognosis. J Am Coll Cardiol, 74:2361-2364.","DOI":"10.1016\/j.jacc.2019.09.042"},{"key":"key-10.14336\/AD.2024.1298-12","doi-asserted-by":"crossref","unstructured":"Xu X, Wang JJ, Zhao H, Miao K, Cui G, Zhang Y, et al. (2022). Variant Angina is Associated with Myocarditis. J Inflamm Res, 15:4939-4949.","DOI":"10.2147\/JIR.S378152"},{"key":"key-10.14336\/AD.2024.1298-13","doi-asserted-by":"crossref","unstructured":"Joshi PH, de Lemos JA (2021). Diagnosis and Management of Stable Angina: A Review. Jama, 325:1765-1778.","DOI":"10.1001\/jama.2021.1527"},{"key":"key-10.14336\/AD.2024.1298-14","doi-asserted-by":"crossref","unstructured":"Aksu E, Cuglan B, Ozturk S, Eren A, Yalta K, Turhan H, et al. (2024). Nitrate-Induced Headache Response in Patients with Coronary Artery Disease and Coronary Artery Ectasia: A Retrospective Case-Control Study. Heart and Mind, 8:215-220.","DOI":"10.4103\/hm.HM-D-23-00049"},{"key":"key-10.14336\/AD.2024.1298-15","doi-asserted-by":"crossref","unstructured":"Chen H, Wang Z, Qin M, Zhang B, Lin L, Ma Q, et al. (2021). Comprehensive Metabolomics Identified the Prominent Role of Glycerophospholipid Metabolism in Coronary Artery Disease Progression. Front Mol Biosci, 8:632950.","DOI":"10.3389\/fmolb.2021.632950"},{"key":"key-10.14336\/AD.2024.1298-16","doi-asserted-by":"crossref","unstructured":"Beltrame JF (2022). Management of vasospastic angina. Heart, 109:70-77.","DOI":"10.1136\/heartjnl-2022-321268"},{"key":"key-10.14336\/AD.2024.1298-17","doi-asserted-by":"crossref","unstructured":"Fukaya H, Ako J, Yasuda S, Kaikita K, Akao M, Matoba T, et al. (2021). Aspirin versus P2Y(12) inhibitors with anticoagulation therapy for atrial fibrillation. Heart, 107:1731-1738.","DOI":"10.1136\/heartjnl-2021-319321"},{"key":"key-10.14336\/AD.2024.1298-18","doi-asserted-by":"crossref","unstructured":"Chakraborty R, Roy S (2021). Angiotensin-converting enzyme inhibitors from plants: A review of their diversity, modes of action, prospects, and concerns in the management of diabetes-centric complications. J Integr Med, 19:478-492.","DOI":"10.1016\/j.joim.2021.09.006"},{"key":"key-10.14336\/AD.2024.1298-19","doi-asserted-by":"crossref","unstructured":"Chen S, Sun Y, Neoh KH, Chen A, Li W, Yang X, et al. (2017). Microfluidic assay of circulating endothelial cells in coronary artery disease patients with angina pectoris. PLoS One, 12:e0181249.","DOI":"10.1371\/journal.pone.0181249"},{"key":"key-10.14336\/AD.2024.1298-20","doi-asserted-by":"crossref","unstructured":"D'Alessandra Y, Carena MC, Spazzafumo L, Martinelli F, Bassetti B, Devanna P, et al. (2013). Diagnostic potential of plasmatic MicroRNA signatures in stable and unstable angina. PLoS One, 8:e80345.","DOI":"10.1371\/journal.pone.0080345"},{"key":"key-10.14336\/AD.2024.1298-21","doi-asserted-by":"crossref","unstructured":"Babu M, Snyder M (2023). Multi-Omics Profiling for Health. Mol Cell Proteomics, 22:100561.","DOI":"10.1016\/j.mcpro.2023.100561"},{"key":"key-10.14336\/AD.2024.1298-22","doi-asserted-by":"crossref","unstructured":"Subramanian I, Verma S, Kumar S, Jere A, Anamika K (2020). Multi-omics Data Integration, Interpretation, and Its Application. Bioinform Biol Insights, 14:1177932219899051.","DOI":"10.1177\/1177932219899051"},{"key":"key-10.14336\/AD.2024.1298-23","doi-asserted-by":"crossref","unstructured":"Jin N, Cheng L, Geng Q (2024). Multiomics on Mental Stress-Induced Myocardial Ischemia: A Narrative Review. Heart and Mind, 8:15-20.","DOI":"10.4103\/hm.HM-D-23-00021"},{"key":"key-10.14336\/AD.2024.1298-24","doi-asserted-by":"crossref","unstructured":"Nguyen N, Jennen D, Kleinjans J (2022). Omics technologies to understand drug toxicity mechanisms. Drug Discov Today, 27:103348.","DOI":"10.1016\/j.drudis.2022.103348"},{"key":"key-10.14336\/AD.2024.1298-25","doi-asserted-by":"crossref","unstructured":"Zhan C, Tang T, Wu E, Zhang Y, He M, Wu R, et al. (2023). From multi-omics approaches to personalized medicine in myocardial infarction. Front Cardiovasc Med, 10:1250340.","DOI":"10.3389\/fcvm.2023.1250340"},{"key":"key-10.14336\/AD.2024.1298-26","doi-asserted-by":"crossref","unstructured":"Bai H, Sun K, Wu JH, Zhong ZH, Xu SL, Zhang HR, et al. (2020). Proteomic and metabolomic characterization of cardiac tissue in acute myocardial ischemia injury rats. PLoS One, 15:e0231797.","DOI":"10.1371\/journal.pone.0231797"},{"key":"key-10.14336\/AD.2024.1298-27","doi-asserted-by":"crossref","unstructured":"Zou L, Wang X, Guo Z, Sun H, Shao C, Yang Y, et al. (2019). Differential urinary proteomics analysis of myocardial infarction using iTRAQ quantification. Mol Med Rep, 19:3972-3988.","DOI":"10.3892\/mmr.2019.10088"},{"key":"key-10.14336\/AD.2024.1298-28","doi-asserted-by":"crossref","unstructured":"Chan MY, Efthymios M, Tan SH, Pickering JW, Troughton R, Pemberton C, et al. (2020). Prioritizing Candidates of Post-Myocardial Infarction Heart Failure Using Plasma Proteomics and Single-Cell Transcriptomics. Circulation, 142:1408-1421.","DOI":"10.1161\/CIRCULATIONAHA.119.045158"},{"key":"key-10.14336\/AD.2024.1298-29","doi-asserted-by":"crossref","unstructured":"Moazzami K, Wittbrodt MT, Alkhalaf M, Lima BB, Nye JA, Mehta PK, et al. (2020). Association Between Mental Stress-Induced Inferior Frontal Cortex Activation and Angina in Coronary Artery Disease. Circ Cardiovasc Imaging, 13:e010710.","DOI":"10.1161\/CIRCIMAGING.120.010710"},{"key":"key-10.14336\/AD.2024.1298-30","doi-asserted-by":"crossref","unstructured":"Shao C, Wang J, Tian J, Tang YD (2020). Coronary Artery Disease: From Mechanism to Clinical Practice. Adv Exp Med Biol, 1177:1-36.","DOI":"10.1007\/978-981-15-2517-9_1"},{"key":"key-10.14336\/AD.2024.1298-31","doi-asserted-by":"crossref","unstructured":"Nurmohamed NS, Kraaijenhof JM, Mayr M, Nicholls SJ, Koenig W, Catapano AL, et al. (2023). Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction. Eur Heart J, 44:1594-1607.","DOI":"10.1093\/eurheartj\/ehad161"},{"key":"key-10.14336\/AD.2024.1298-32","doi-asserted-by":"crossref","unstructured":"Zafari N, Bathaei P, Velayati M, Khojasteh-Leylakoohi F, Khazaei M, Fiuji H, et al. (2023). Integrated analysis of multi-omics data for the discovery of biomarkers and therapeutic targets for colorectal cancer. Comput Biol Med, 155:106639.","DOI":"10.1016\/j.compbiomed.2023.106639"},{"key":"key-10.14336\/AD.2024.1298-33","doi-asserted-by":"crossref","unstructured":"Wei X, He Y, Wan H, Yin J, Lin B, Ding Z, et al. (2023). Integrated transcriptomics, proteomics and metabolomics to identify biomarkers of astragaloside IV against cerebral ischemic injury in rats. Food Funct, 14:3588-3599.","DOI":"10.1039\/D2FO03030F"},{"key":"key-10.14336\/AD.2024.1298-34","doi-asserted-by":"crossref","unstructured":"Montaner J, Ramiro L, Simats A, Tiedt S, Makris K, Jickling GC, et al. (2020). Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke. Nat Rev Neurol, 16:247-264.","DOI":"10.1038\/s41582-020-0350-6"},{"key":"key-10.14336\/AD.2024.1298-35","doi-asserted-by":"crossref","unstructured":"Juan D, Santpere G, Kelley JL, Cornejo OE, Marques-Bonet T (2023). Current advances in primate genomics: novel approaches for understanding evolution and disease. Nat Rev Genet, 24:314-331.","DOI":"10.1038\/s41576-022-00554-w"},{"key":"key-10.14336\/AD.2024.1298-36","doi-asserted-by":"crossref","unstructured":"Green ED, Watson JD, Collins FS (2015). Human Genome Project: Twenty-five years of big biology. Nature, 526:29-31.","DOI":"10.1038\/526029a"},{"key":"key-10.14336\/AD.2024.1298-37","doi-asserted-by":"crossref","unstructured":"Downes K, Megy K, Duarte D, Vries M, Gebhart J, Hofer S, et al. (2019). Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders. Blood, 134:2082-2091.","DOI":"10.1182\/blood.2018891192"},{"key":"key-10.14336\/AD.2024.1298-38","doi-asserted-by":"crossref","unstructured":"Zhu K, Liu Q, Zhou Y, Tao C, Zhao Z, Sun J, et al. (2015). Oncogenes and tumor suppressor genes: comparative genomics and network perspectives. BMC Genomics, 16 Suppl 7:S8.","DOI":"10.1186\/1471-2164-16-S7-S8"},{"key":"key-10.14336\/AD.2024.1298-39","doi-asserted-by":"crossref","unstructured":"Wang N, Lu SF, Chen H, Wang JF, Fu SP, Hu CJ, et al. (2015). A protocol of histone modification-based mechanistic study of acupuncture in patients with stable angina pectoris. BMC Complement Altern Med, 15:139.","DOI":"10.1186\/s12906-015-0653-0"},{"key":"key-10.14336\/AD.2024.1298-40","doi-asserted-by":"crossref","unstructured":"Niarchou M, Gustavson DE, Sathirapongsasuti JF, Anglada-Tort M, Eising E, Bell E, et al. (2022). Genome-wide association study of musical beat synchronization demonstrates high polygenicity. Nat Hum Behav, 6:1292-1309.","DOI":"10.1038\/s41562-022-01359-x"},{"key":"key-10.14336\/AD.2024.1298-41","doi-asserted-by":"crossref","unstructured":"de Boer S, Baran Y, Garcia-Garcia HM, Eskin I, Lenzen MJ, Kleber ME, et al. (2018). The European Collaborative Project on Inflammation and Vascular Wall Remodeling in Atherosclerosis - Intravascular Ultrasound (ATHEROREMO-IVUS) study. EuroIntervention, 14:194-203.","DOI":"10.4244\/EIJ-D-17-00180"},{"key":"key-10.14336\/AD.2024.1298-42","doi-asserted-by":"crossref","unstructured":"Yan J, Zeng J, Xie Z, Liu D, Wang L, Chen Z (2016). Association of rs10811656 on 9P21.3 with the risk of coronary artery disease in a Chinese population. Lipids Health Dis, 15:126.","DOI":"10.1186\/s12944-016-0296-2"},{"key":"key-10.14336\/AD.2024.1298-43","doi-asserted-by":"crossref","unstructured":"Liu S, Zhong Z, Zhong W, Weng R, Liu J, Gu X, et al. (2020). Comprehensive analysis of T-cell receptor repertoire in patients with acute coronary syndrome by high-throughput sequencing. BMC Cardiovasc Disord, 20:253.","DOI":"10.1186\/s12872-020-01538-6"},{"key":"key-10.14336\/AD.2024.1298-44","doi-asserted-by":"crossref","unstructured":"Weng R, Liu S, Gu X, Zhong Z (2022). Characterization of the B cell receptor repertoire of patients with acute coronary syndrome. Genes Genomics, 44:19-28.","DOI":"10.1007\/s13258-021-01110-2"},{"key":"key-10.14336\/AD.2024.1298-45","doi-asserted-by":"crossref","unstructured":"Harrap SB, Zammit KS, Wong ZY, Williams FM, Bahlo M, Tonkin AM, et al. (2002). Genome-wide linkage analysis of the acute coronary syndrome suggests a locus on chromosome 2. Arterioscler Thromb Vasc Biol, 22:874-8.","DOI":"10.1161\/01.ATV.0000016258.40568.F1"},{"key":"key-10.14336\/AD.2024.1298-46","doi-asserted-by":"crossref","unstructured":"Raaz-Schrauder D, Ekici AB, Munoz LE, Klinghammer L, Voll RE, Leusen JH, et al. (2012). Patients with unstable angina pectoris show an increased frequency of the Fc gamma RIIa R131 allele. Autoimmunity, 45:556-64.","DOI":"10.3109\/08916934.2012.682665"},{"key":"key-10.14336\/AD.2024.1298-47","doi-asserted-by":"crossref","unstructured":"Fantino M, Paquette M, Bernard S, Baass A (2021). ANKS1A genotype predicts cardiovascular events in patients with familial hypercholesterolemia. J Clin Lipidol, 15:602-607.","DOI":"10.1016\/j.jacl.2021.05.006"},{"key":"key-10.14336\/AD.2024.1298-48","doi-asserted-by":"crossref","unstructured":"Wang XB, Han YD, Sabina S, Cui NH, Zhang S, Liu ZJ, et al. (2016). HDAC9 Variant Rs2107595 Modifies Susceptibility to Coronary Artery Disease and the Severity of Coronary Atherosclerosis in a Chinese Han Population. PLoS One, 11:e0160449.","DOI":"10.1371\/journal.pone.0160449"},{"key":"key-10.14336\/AD.2024.1298-49","doi-asserted-by":"crossref","unstructured":"Agha G, Mendelson MM, Ward-Caviness CK, Joehanes R, Huan T, Gondalia R, et al. (2019). Blood Leukocyte DNA Methylation Predicts Risk of Future Myocardial Infarction and Coronary Heart Disease. Circulation, 140:645-657.","DOI":"10.1161\/CIRCULATIONAHA.118.039357"},{"key":"key-10.14336\/AD.2024.1298-50","doi-asserted-by":"crossref","unstructured":"Suzuki S, Yoshimura M, Nakayama M, Abe K, Yamamuro M, Nagayoshi Y, et al. (2007). A novel genetic marker for coronary spasm in women from a genome-wide single nucleotide polymorphism analysis. Pharmacogenet Genomics, 17:919-30.","DOI":"10.1097\/FPC.0b013e328136bd35"},{"key":"key-10.14336\/AD.2024.1298-51","doi-asserted-by":"crossref","unstructured":"Ogimoto A, Shigematsu Y, Nakura J, Hara Y, Ohtsuka T, Kohara K, et al. (2005). Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) in patients with coexistent hypertrophic cardiomyopathy and coronary spastic angina. J Mol Med (Berl), 83:619-25.","DOI":"10.1007\/s00109-005-0641-9"},{"key":"key-10.14336\/AD.2024.1298-52","doi-asserted-by":"crossref","unstructured":"Park JS, Zhang SY, Jo SH, Seo JB, Li L, Park KW, et al. (2006). Common adrenergic receptor polymorphisms as novel risk factors for vasospastic angina. Am Heart J, 151:864-9.","DOI":"10.1016\/j.ahj.2005.06.009"},{"key":"key-10.14336\/AD.2024.1298-53","doi-asserted-by":"crossref","unstructured":"Welsh SA, Gardini A (2023). Genomic regulation of transcription and RNA processing by the multitasking Integrator complex. Nat Rev Mol Cell Biol, 24:204-220.","DOI":"10.1038\/s41580-022-00534-2"},{"key":"key-10.14336\/AD.2024.1298-54","doi-asserted-by":"crossref","unstructured":"Floriddia E (2023). Transcriptomics and ALS outcome. Nat Neurosci, 26:175.","DOI":"10.1038\/s41593-023-01262-2"},{"key":"key-10.14336\/AD.2024.1298-55","doi-asserted-by":"crossref","unstructured":"Jackson SW, Alpers CE (2022). Lupus nephritis transcriptomics across space and time. Kidney Int, 102:694-696.","DOI":"10.1016\/j.kint.2022.06.028"},{"key":"key-10.14336\/AD.2024.1298-56","doi-asserted-by":"crossref","unstructured":"Krausgruber T, Redl A, Barreca D, Doberer K, Romanovskaia D, Dobnikar L, et al. (2023). Single-cell and spatial transcriptomics reveal aberrant lymphoid developmental programs driving granuloma formation. Immunity, 56:289-306.e7.","DOI":"10.1016\/j.immuni.2023.01.014"},{"key":"key-10.14336\/AD.2024.1298-57","doi-asserted-by":"crossref","unstructured":"Nakayama M, Kudoh T, Kaikita K, Yoshimura M, Oshima S, Miyamoto Y, et al. (2008). Class A macrophage scavenger receptor gene expression levels in peripheral blood mononuclear cells specifically increase in patients with acute coronary syndrome. Atherosclerosis, 198:426-33.","DOI":"10.1016\/j.atherosclerosis.2007.09.006"},{"key":"key-10.14336\/AD.2024.1298-58","unstructured":"De Iuliis V, Dadorante V, Marino A, Griffo I, Pennelli A, Breda V, et al. (2017). Cytokine expression profile and blood parameter evaluation of patients undergoing cardiac surgery. J Biol Regul Homeost Agents, 31:1109-1113."},{"key":"key-10.14336\/AD.2024.1298-59","doi-asserted-by":"crossref","unstructured":"Zhou XR, Song N, Luo JY, Zhai H, Li XM, Zhao Q, et al. (2019). Expression profiles and potential functions of long non-coding RNA in stable angina pectoris patients from Uyghur population of China. Biosci Rep, 39:","DOI":"10.1042\/BSR20190364"},{"key":"key-10.14336\/AD.2024.1298-60","doi-asserted-by":"crossref","unstructured":"Liu S, Guo X, Zhong W, Weng R, Liu J, Gu X, et al. (2020). Circulating MicroRNA Expression Profiles in Patients with Stable and Unstable Angina. Clinics (Sao Paulo), 75:e1546.","DOI":"10.6061\/clinics\/2020\/e1546"},{"key":"key-10.14336\/AD.2024.1298-61","doi-asserted-by":"crossref","unstructured":"Cui Y, Song J, Li S, Lee C, Zhang F, Chen H (2018). Plasmatic MicroRNA Signatures in Elderly People with Stable and Unstable Angina. Int Heart J, 59:43-50.","DOI":"10.1536\/ihj.17-063"},{"key":"key-10.14336\/AD.2024.1298-62","doi-asserted-by":"crossref","unstructured":"Ren J, Zhang J, Xu N, Han G, Geng Q, Song J, et al. (2013). Signature of circulating microRNAs as potential biomarkers in vulnerable coronary artery disease. PLoS One, 8:e80738.","DOI":"10.1371\/journal.pone.0080738"},{"key":"key-10.14336\/AD.2024.1298-63","doi-asserted-by":"crossref","unstructured":"Messner CB, Demichev V, Muenzner J, Aulakh SK, Barthel N, R\u00f6hl A, et al. (2023). The proteomic landscape of genome-wide genetic perturbations. Cell, 186:2018-2034.e21.","DOI":"10.1016\/j.cell.2023.03.026"},{"key":"key-10.14336\/AD.2024.1298-64","doi-asserted-by":"crossref","unstructured":"Bai JPF, Yu LR (2023). Modeling Clinical Phenotype Variability: Consideration of Genomic Variations, Computational Methods, and Quantitative Proteomics. J Pharm Sci, 112:904-908.","DOI":"10.1016\/j.xphs.2022.10.016"},{"key":"key-10.14336\/AD.2024.1298-65","doi-asserted-by":"crossref","unstructured":"Liu L, Luo F (2022). Alterations in the fecal microbiota and serum metabolome in unstable angina pectoris patients. Front Biosci (Landmark Ed), 27:100.","DOI":"10.31083\/j.fbl2703100"},{"key":"key-10.14336\/AD.2024.1298-66","doi-asserted-by":"crossref","unstructured":"Cheow ESH, Cheng WC, Yap T, Dutta B, Lee CN, Kleijn DPV, et al. (2018). Myocardial Injury Is Distinguished from Stable Angina by a Set of Candidate Plasma Biomarkers Identified Using iTRAQ\/MRM-Based Approach. J Proteome Res, 17:499-515.","DOI":"10.1021\/acs.jproteome.7b00651"},{"key":"key-10.14336\/AD.2024.1298-67","doi-asserted-by":"crossref","unstructured":"Volpi E, Giusti L, Ciregia F, Da Valle Y, Giannaccini G, Berti S, et al. (2012). Platelet proteome and clopidogrel response in patients with stable angina undergoing percutaneous coronary intervention. Clin Biochem, 45:758-65.","DOI":"10.1016\/j.clinbiochem.2012.03.028"},{"key":"key-10.14336\/AD.2024.1298-68","doi-asserted-by":"crossref","unstructured":"Banfi C, Brioschi M, Marenzi G, De Metrio M, Camera M, Mussoni L, et al. (2010). Proteome of platelets in patients with coronary artery disease. Exp Hematol, 38:341-50.","DOI":"10.1016\/j.exphem.2010.03.001"},{"key":"key-10.14336\/AD.2024.1298-69","doi-asserted-by":"crossref","unstructured":"Lorentzen LG, Hansen GM, Iversen KK, Bundgaard H, Davies MJ (2022). Proteomic Characterization of Atherosclerotic Lesions In Situ Using Percutaneous Coronary Intervention Angioplasty Balloons-Brief Report. Arterioscler Thromb Vasc Biol, 42:857-864.","DOI":"10.1161\/ATVBAHA.122.317491"},{"key":"key-10.14336\/AD.2024.1298-70","doi-asserted-by":"crossref","unstructured":"M\u00e1jek P, Reicheltov\u00e1 Z, Suttnar J, Mal\u00fd M, Oravec M, Pe\u010d\u00e1nkov\u00e1 K, et al. (2011). Plasma proteome changes in cardiovascular disease patients: novel isoforms of apolipoprotein A1. J Transl Med, 9:84.","DOI":"10.1186\/1479-5876-9-84"},{"key":"key-10.14336\/AD.2024.1298-71","doi-asserted-by":"crossref","unstructured":"Jung SH, Won KJ, Lee KP, Kim HJ, Seo EH, Lee HM, et al. (2015). The serum protein fetuin-B is involved in the development of acute myocardial infarction. Clin Sci (Lond), 129:27-38.","DOI":"10.1042\/CS20140462"},{"key":"key-10.14336\/AD.2024.1298-72","doi-asserted-by":"crossref","unstructured":"Fillet M, Deroyer C, Cobraiville G, Le Goff C, Cavalier E, Chapelle JP, et al. (2013). Identification of protein biomarkers associated with cardiac ischemia by a proteomic approach. Biomarkers, 18:614-24.","DOI":"10.3109\/1354750X.2013.838306"},{"key":"key-10.14336\/AD.2024.1298-73","doi-asserted-by":"crossref","unstructured":"Ni XN, Yan SB, Zhang K, Sai WW, Zhang QY, Ti Y, et al. (2020). Serum complement C1q level is associated with acute coronary syndrome. Mol Immunol, 120:130-135.","DOI":"10.1016\/j.molimm.2020.02.012"},{"key":"key-10.14336\/AD.2024.1298-74","doi-asserted-by":"crossref","unstructured":"Wykrzykowska JJ, Garcia-Garcia HM, Goedhart D, Zalewski A, Serruys PW (2011). Differential protein biomarker expression and their time-course in patients with a spectrum of stable and unstable coronary syndromes in the Integrated Biomarker and Imaging Study-1 (IBIS-1). Int J Cardiol, 149:10-6.","DOI":"10.1016\/j.ijcard.2009.11.033"},{"key":"key-10.14336\/AD.2024.1298-75","doi-asserted-by":"crossref","unstructured":"Liu J, Chen B, Lu H, Chen Q, Li JC (2023). Identification of novel candidate biomarkers for acute myocardial infarction by the Olink proteomics platform. Clin Chim Acta, 548:117506.","DOI":"10.1016\/j.cca.2023.117506"},{"key":"key-10.14336\/AD.2024.1298-76","doi-asserted-by":"crossref","unstructured":"Mateos-C\u00e1ceres PJ, Garc\u00eda-M\u00e9ndez A, L\u00f3pez Farr\u00e9 A, Macaya C, N\u00fa\u00f1ez A, G\u00f3mez J, et al. (2004). Proteomic analysis of plasma from patients during an acute coronary syndrome. J Am Coll Cardiol, 44:1578-83.","DOI":"10.1016\/j.jacc.2004.06.073"},{"key":"key-10.14336\/AD.2024.1298-77","doi-asserted-by":"crossref","unstructured":"Katam R, Lin C, Grant K, Katam CS, Chen S (2022). Advances in Plant Metabolomics and Its Applications in Stress and Single-Cell Biology. Int J Mol Sci, 23:","DOI":"10.3390\/ijms23136985"},{"key":"key-10.14336\/AD.2024.1298-78","doi-asserted-by":"crossref","unstructured":"Chumachenko MS, Waseem TV, Fedorovich SV (2022). Metabolomics and metabolites in ischemic stroke. Rev Neurosci, 33:181-205.","DOI":"10.1515\/revneuro-2021-0048"},{"key":"key-10.14336\/AD.2024.1298-79","doi-asserted-by":"crossref","unstructured":"Pereira PR, Carrageta DF, Oliveira PF, Rodrigues A, Alves MG, Monteiro MP (2022). Metabolomics as a tool for the early diagnosis and prognosis of diabetic kidney disease. Med Res Rev, 42:1518-1544.","DOI":"10.1002\/med.21883"},{"key":"key-10.14336\/AD.2024.1298-80","doi-asserted-by":"crossref","unstructured":"Jacob M, Lopata AL, Dasouki M, Abdel Rahman AM (2019). Metabolomics toward personalized medicine. Mass Spectrom Rev, 38:221-238.","DOI":"10.1002\/mas.21548"},{"key":"key-10.14336\/AD.2024.1298-81","doi-asserted-by":"crossref","unstructured":"Astarita G, Kelly RS, Lasky-Su J (2023). Metabolomics and lipidomics strategies in modern drug discovery and development. Drug Discov Today, 28:103751.","DOI":"10.1016\/j.drudis.2023.103751"},{"key":"key-10.14336\/AD.2024.1298-82","doi-asserted-by":"crossref","unstructured":"Madsen PA, Curtasu MV, Canibe N, Hedemann MS, Pedersen MLM, Lauridsen C (2022). Non-targeted metabolomics of saliva to explore potential biomarkers for gastric ulceration in pigs fed hemp. Animal, 16:100477.","DOI":"10.1016\/j.animal.2022.100477"},{"key":"key-10.14336\/AD.2024.1298-83","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Hern\u00e1ndez Y, Mon\u00e1rrez-Espino J, Oostdam AH, Delgado JEC, Zhang L, Zheng J, et al. (2021). Targeted metabolomics identifies high performing diagnostic and prognostic biomarkers for COVID-19. Sci Rep, 11:14732.","DOI":"10.1038\/s41598-021-94171-y"},{"key":"key-10.14336\/AD.2024.1298-84","doi-asserted-by":"crossref","unstructured":"Fan Y, Li Y, Chen Y, Zhao YJ, Liu LW, Li J, et al. (2016). Comprehensive Metabolomic Characterization of Coronary Artery Diseases. J Am Coll Cardiol, 68:1281-93.","DOI":"10.1016\/j.jacc.2016.06.044"},{"key":"key-10.14336\/AD.2024.1298-85","doi-asserted-by":"crossref","unstructured":"Zhang L, Wei TT, Li Y, Li J, Fan Y, Huang FQ, et al. (2018). Functional Metabolomics Characterizes a Key Role for N-Acetylneuraminic Acid in Coronary Artery Diseases. Circulation, 137:1374-1390.","DOI":"10.1161\/CIRCULATIONAHA.117.031139"},{"key":"key-10.14336\/AD.2024.1298-86","doi-asserted-by":"crossref","unstructured":"Zheng L, Mingxue Z, Zeng L, Yushi Z, Yuhan A, Yi Y, et al. (2022). A Landscape of Metabonomics for Intermingled Phlegm and Blood Stasis and Its Concurrent Syndromes in Stable Angina Pectoris of Coronary Heart Disease. Front Cardiovasc Med, 9:871142.","DOI":"10.3389\/fcvm.2022.871142"},{"key":"key-10.14336\/AD.2024.1298-87","doi-asserted-by":"crossref","unstructured":"Lu J, Chen B, Chen T, Guo S, Xue X, Chen Q, et al. (2017). Comprehensive metabolomics identified lipid peroxidation as a prominent feature in human plasma of patients with coronary heart diseases. Redox Biol, 12:899-907.","DOI":"10.1016\/j.redox.2017.04.032"},{"key":"key-10.14336\/AD.2024.1298-88","doi-asserted-by":"crossref","unstructured":"Gill A, Aldosoky W, Ong MBH, Mir T, Dar T, Abohashem S (2023). A Narrative Review on Mental Stress and Cardiovascular Disease: Evidence, Mechanisms, and Potential Interventions. 7:62-69.","DOI":"10.4103\/hm.HM-D-22-00002"},{"key":"key-10.14336\/AD.2024.1298-89","doi-asserted-by":"crossref","unstructured":"Gupta A, Kumar S, Kashyap S, Kumar D, Kapoor A (2016). Nuclear Magnetic Resonance-Based Metabolomics of Human Filtered Serum: A Great White Hope in Appraisal of Chronic Stable Angina and Myocardial Infarction. J Appl Lab Med, 1:280-293.","DOI":"10.1373\/jalm.2016.020776"},{"key":"key-10.14336\/AD.2024.1298-90","doi-asserted-by":"crossref","unstructured":"DeRatt BN, Ralat MA, Lysne V, Tayyari F, Dhar I, Edison AS, et al. (2017). Metabolomic Evaluation of the Consequences of Plasma Cystathionine Elevation in Adults with Stable Angina Pectoris. J Nutr, 147:1658-1668.","DOI":"10.3945\/jn.117.254029"},{"key":"key-10.14336\/AD.2024.1298-91","doi-asserted-by":"crossref","unstructured":"Calder\u00f3n-Santiago M, Priego-Capote F, Galache-Osuna JG, Luque de Castro MD (2014). Analysis of serum phospholipid profiles by liquid chromatography-tandem mass spectrometry in high resolution mode for evaluation of atherosclerotic patients. J Chromatogr A, 1371:154-62.","DOI":"10.1016\/j.chroma.2014.10.052"},{"key":"key-10.14336\/AD.2024.1298-92","doi-asserted-by":"crossref","unstructured":"Zhong Z, Liu J, Zhang Q, Zhong W, Li B, Li C, et al. (2019). Targeted metabolomic analysis of plasma metabolites in patients with coronary heart disease in southern China. Medicine (Baltimore), 98:e14309.","DOI":"10.1097\/MD.0000000000014309"},{"key":"key-10.14336\/AD.2024.1298-93","doi-asserted-by":"crossref","unstructured":"Yu XH, Sun J, Wang Y, Zhou YB (2017). Biomarkers of unstable angina pectoris and yangxin decoction intervention: An exploratory metabonomics study of blood plasma. Medicine (Baltimore), 96:e6998.","DOI":"10.1097\/MD.0000000000006998"},{"key":"key-10.14336\/AD.2024.1298-94","doi-asserted-by":"crossref","unstructured":"Wang J, Xu W, Zhao H, Chen J, Zhu B, Li X, et al. (2019). Identification of potential plasma biomarkers and metabolic dysfunction for unstable angina pectoris and its complication based on global metabolomics. Biosci Rep, 39:","DOI":"10.1042\/BSR20181658"},{"key":"key-10.14336\/AD.2024.1298-95","unstructured":"PouralijanAmiri M, Khoshkam M, Madadi R, Kamali K, Faghanzadeh Ganji G, Salek R, et al. (2020). NMR-based plasma metabolic profiling in patients with unstable angina. Iran J Basic Med Sci, 23:311-320."},{"key":"key-10.14336\/AD.2024.1298-96","doi-asserted-by":"crossref","unstructured":"Panteris E, Deda O, Papazoglou AS, Karagiannidis E, Liapikos T, Begou O, et al. (2022). Machine Learning Algorithm to Predict Obstructive Coronary Artery Disease: Insights from the CorLipid Trial. Metabolites, 12:","DOI":"10.3390\/metabo12090816"},{"key":"key-10.14336\/AD.2024.1298-97","doi-asserted-by":"crossref","unstructured":"Liu J, Huang L, Shi X, Gu C, Xu H, Liu S (2021). Clinical Parameters and Metabolomic Biomarkers That Predict Inhospital Outcomes in Patients With ST-Segment Elevated Myocardial Infarctions. Front Physiol, 12:820240.","DOI":"10.3389\/fphys.2021.820240"},{"key":"key-10.14336\/AD.2024.1298-98","doi-asserted-by":"crossref","unstructured":"Ali SE, Farag MA, Holvoet P, Hanafi RS, Gad MZ (2016). A Comparative Metabolomics Approach Reveals Early Biomarkers for Metabolic Response to Acute Myocardial Infarction. Sci Rep, 6:36359.","DOI":"10.1038\/srep36359"},{"key":"key-10.14336\/AD.2024.1298-99","doi-asserted-by":"crossref","unstructured":"Chen H, He Y (2022). Machine Learning Approaches in Traditional Chinese Medicine: A Systematic Review. Am J Chin Med, 50:91-131.","DOI":"10.1142\/S0192415X22500045"},{"key":"key-10.14336\/AD.2024.1298-100","doi-asserted-by":"crossref","unstructured":"Maida E, Abbadessa G, Cocco E, Valentino P, Lerede A, Frau J, et al. (2024). Identifying definite patterns of unmet needs in patients with multiple sclerosis using unsupervised machine learning. Neurol Sci, 45:3333-3345.","DOI":"10.1007\/s10072-024-07416-9"},{"key":"key-10.14336\/AD.2024.1298-101","doi-asserted-by":"crossref","unstructured":"Schroder J, Mygind ND, Frestad D, Michelsen M, Suhrs HE, Bove KB, et al. (2019). Pro-inflammatory biomarkers in women with non-obstructive angina pectoris and coronary microvascular dysfunction. Int J Cardiol Heart Vasc, 24:100370.","DOI":"10.1016\/j.ijcha.2019.100370"},{"key":"key-10.14336\/AD.2024.1298-102","doi-asserted-by":"crossref","unstructured":"Zhao H, Chen J, Shi Q, Ma X, Yang Y, Luo L, et al. (2012). Metabolomics-based study of clinical and animal plasma samples in coronary heart disease with blood stasis syndrome. Evid Based Complement Alternat Med, 2012:638723.","DOI":"10.1155\/2012\/638723"},{"key":"key-10.14336\/AD.2024.1298-103","doi-asserted-by":"crossref","unstructured":"Cina A, Galbusera F (2024). Advancing spine care through AI and machine learning: overview and applications. EFORT Open Rev, 9:422-433.","DOI":"10.1530\/EOR-24-0019"},{"key":"key-10.14336\/AD.2024.1298-104","doi-asserted-by":"crossref","unstructured":"McGilligan V, Watterson S, Rjoob K, Chemaly M, Bond R, Iftikhar A, et al. (2019). An exploratory analysis investigating blood protein biomarkers to augment ECG diagnosis of ACS. J Electrocardiol, 57s:S92-s97.","DOI":"10.1016\/j.jelectrocard.2019.09.002"},{"key":"key-10.14336\/AD.2024.1298-105","doi-asserted-by":"crossref","unstructured":"Lu R, Lin W, Jin Q, Wang D, Zhang C, Wang H, et al. (2024). Plasma Metabolic Profiling and Multiclass Diagnostic Model Development for Stable Angina Pectoris and Acute Myocardial Infarction. ACS Omega, 9:16322-16333.","DOI":"10.1021\/acsomega.3c10474"},{"key":"key-10.14336\/AD.2024.1298-106","doi-asserted-by":"crossref","unstructured":"Fu M, He R, Zhang Z, Ma F, Shen L, Zhang Y, et al. (2023). Multinomial machine learning identifies independent biomarkers by integrated metabolic analysis of acute coronary syndrome. Sci Rep, 13:20535.","DOI":"10.1038\/s41598-023-47783-5"},{"key":"key-10.14336\/AD.2024.1298-107","doi-asserted-by":"crossref","unstructured":"Levy BI, Heusch G, Camici PG (2019). The many faces of myocardial ischaemia and angina. Cardiovasc Res, 115:1460-1470.","DOI":"10.1093\/cvr\/cvz160"},{"key":"key-10.14336\/AD.2024.1298-108","doi-asserted-by":"crossref","unstructured":"Crea F (2021). The challenge of risk stratification in suspected angina, in myocardial infarction without risk factors, and in frail patients. Eur Heart J, 42:3807-3811.","DOI":"10.1093\/eurheartj\/ehab693"},{"key":"key-10.14336\/AD.2024.1298-109","doi-asserted-by":"crossref","unstructured":"Randi AM, Biguzzi E, Falciani F, Merlini P, Blakemore S, Bramucci E, et al. (2003). Identification of differentially expressed genes in coronary atherosclerotic plaques from patients with stable or unstable angina by cDNA array analysis. J Thromb Haemost, 1:829-35.","DOI":"10.1046\/j.1538-7836.2003.00113.x"},{"key":"key-10.14336\/AD.2024.1298-110","doi-asserted-by":"crossref","unstructured":"Bolton JL, Stewart MC, Wilson JF, Anderson N, Price JF (2013). Improvement in prediction of coronary heart disease risk over conventional risk factors using SNPs identified in genome-wide association studies. PLoS One, 8:e57310.","DOI":"10.1371\/journal.pone.0057310"},{"key":"key-10.14336\/AD.2024.1298-111","doi-asserted-by":"crossref","unstructured":"Hikino K, Koyama S, Ito K, Koike Y, Koido M, Matsumura T, et al. (2024). RNF213 Variants, Vasospastic Angina, and Risk of Fatal Myocardial Infarction. JAMA Cardiol, 9:723-731.","DOI":"10.1001\/jamacardio.2024.1483"},{"key":"key-10.14336\/AD.2024.1298-112","doi-asserted-by":"crossref","unstructured":"Fang J, Yang X, Ni J (2024). RNF213 in moyamoya disease: Genotype-phenotype association and the underlying mechanism. Chin Med J (Engl), 137:2552-2560.","DOI":"10.1097\/CM9.0000000000002985"},{"key":"key-10.14336\/AD.2024.1298-113","doi-asserted-by":"crossref","unstructured":"Huang S, Shui X, He Y, Xue Y, Li J, Li G, et al. (2015). AhR expression and polymorphisms are associated with risk of coronary arterial disease in Chinese population. Sci Rep, 5:8022.","DOI":"10.1038\/srep08022"},{"key":"key-10.14336\/AD.2024.1298-114","doi-asserted-by":"crossref","unstructured":"Neavin DR, Liu D, Ray B, Weinshilboum RM (2018). The Role of the Aryl Hydrocarbon Receptor (AHR) in Immune and Inflammatory Diseases. Int J Mol Sci, 19:","DOI":"10.3390\/ijms19123851"},{"key":"key-10.14336\/AD.2024.1298-115","doi-asserted-by":"crossref","unstructured":"Beitelshees AL, Thomas CD, Empey PE, Stouffer GA, Angiolillo DJ, Franchi F, et al. (2022). CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings. J Am Heart Assoc, 11:e024159.","DOI":"10.1161\/JAHA.121.024159"},{"key":"key-10.14336\/AD.2024.1298-116","doi-asserted-by":"crossref","unstructured":"Wang J, Liu L, Liu C, Cheng N, Mao Q, Chen C, et al. (2023). Identification and analysis of differential miRNA-mRNA interactions in coronary heart disease: an experimental screening approach. Front Cardiovasc Med, 10:1186297.","DOI":"10.3389\/fcvm.2023.1186297"},{"key":"key-10.14336\/AD.2024.1298-117","unstructured":"Ma D, Lu Y, Ye H, Li C, Zhang J, Bao TH, et al. (2024). miR-4685-3p Alleviates Human Brain Microvascular Endothelial Cells Injury by Regulating MMP9. Ann Clin Lab Sci, 54:179-189."},{"key":"key-10.14336\/AD.2024.1298-118","doi-asserted-by":"crossref","unstructured":"Li J, Ge X, Wang X, Liu X, Ma J (2016). Complement System in the Pathogenesis of Benign Lymphoepithelial Lesions of the Lacrimal Gland. PLoS One, 11:e0148290.","DOI":"10.1371\/journal.pone.0148290"},{"key":"key-10.14336\/AD.2024.1298-119","doi-asserted-by":"crossref","unstructured":"Huang ZY, Luo ZY, Cai YR, Chou CH, Yao ML, Pei FX, et al. (2022). Single cell transcriptomics in human osteoarthritis synovium and in silico deconvoluted bulk RNA sequencing. Osteoarthritis Cartilage, 30:475-480.","DOI":"10.1016\/j.joca.2021.12.007"},{"key":"key-10.14336\/AD.2024.1298-120","doi-asserted-by":"crossref","unstructured":"Xu X, Hua X, Mo H, Hu S, Song J (2023). Single-cell RNA sequencing to identify cellular heterogeneity and targets in cardiovascular diseases: from bench to bedside. Basic Res Cardiol, 118:7.","DOI":"10.1007\/s00395-022-00972-1"},{"key":"key-10.14336\/AD.2024.1298-121","doi-asserted-by":"crossref","unstructured":"Liang WL, Liao HL, Liang B (2023). Immune landscape and regulatory mechanisms in human atherosclerotic coronary plaques: Evidence from single-cell and bulk transcriptomics. Heliyon, 9:e19392.","DOI":"10.1016\/j.heliyon.2023.e19392"},{"key":"key-10.14336\/AD.2024.1298-122","doi-asserted-by":"crossref","unstructured":"Schroder J, Zethner-Moller R, Bov\u00e9 KB, Mygind ND, Hasbak P, Michelsen MM, et al. (2018). Protein biomarkers and coronary microvascular dilatation assessed by rubidium-82 PET in women with angina pectoris and no obstructive coronary artery disease. Atherosclerosis, 275:319-327.","DOI":"10.1016\/j.atherosclerosis.2018.06.864"},{"key":"key-10.14336\/AD.2024.1298-123","doi-asserted-by":"crossref","unstructured":"Ngamjariyawat A, Cen J, Wang X, Welsh N (2024). GDF15 Protects Insulin-Producing Beta Cells against Pro-Inflammatory Cytokines and Metabolic Stress via Increased Deamination of Intracellular Adenosine. Int J Mol Sci, 25:","DOI":"10.3390\/ijms25020801"},{"key":"key-10.14336\/AD.2024.1298-124","doi-asserted-by":"crossref","unstructured":"Tuna R, Yi W, Crespo Cruz E, Romero JP, Ren Y, Guan J, et al. (2024). Platelet Biorheology and Mechanobiology in Thrombosis and Hemostasis: Perspectives from Multiscale Computation. Int J Mol Sci, 25:","DOI":"10.20944\/preprints202402.0799.v2"},{"key":"key-10.14336\/AD.2024.1298-125","doi-asserted-by":"crossref","unstructured":"Letertre MPM, Dervilly G, Giraudeau P (2021). Combined Nuclear Magnetic Resonance Spectroscopy and Mass Spectrometry Approaches for Metabolomics. Anal Chem, 93:500-518.","DOI":"10.1021\/acs.analchem.0c04371"},{"key":"key-10.14336\/AD.2024.1298-126","doi-asserted-by":"crossref","unstructured":"Forcisi S, Moritz F, Kanawati B, Tziotis D, Lehmann R, Schmitt-Kopplin P (2013). Liquid chromatography-mass spectrometry in metabolomics research: mass analyzers in ultra high pressure liquid chromatography coupling. J Chromatogr A, 1292:51-65.","DOI":"10.1016\/j.chroma.2013.04.017"},{"key":"key-10.14336\/AD.2024.1298-127","doi-asserted-by":"crossref","unstructured":"Gray LR, Tompkins SC, Taylor EB (2014). Regulation of pyruvate metabolism and human disease. Cell Mol Life Sci, 71:2577-604.","DOI":"10.1007\/s00018-013-1539-2"},{"key":"key-10.14336\/AD.2024.1298-128","doi-asserted-by":"crossref","unstructured":"Zeigerer A, Sekar R, Kleinert M, Nason S, Habegger KM, M\u00fcller TD (2021). Glucagon's Metabolic Action in Health and Disease. Compr Physiol, 11:1759-1783.","DOI":"10.1002\/cphy.c200013"},{"key":"key-10.14336\/AD.2024.1298-129","doi-asserted-by":"crossref","unstructured":"Liu Y, Li Y, Zhang T, Zhao H, Fan S, Cai X, et al. (2020). Analysis of biomarkers and metabolic pathways in patients with unstable angina based on ultra\u2011high\u2011performance liquid chromatography\u2011quadrupole time\u2011of\u2011flight mass spectrometry. Mol Med Rep, 22:3862-3872.","DOI":"10.3892\/mmr.2020.11476"},{"key":"key-10.14336\/AD.2024.1298-130","doi-asserted-by":"crossref","unstructured":"Dai Y, Junho CVC, Schieren L, Wollenhaupt J, Sluimer JC, van der Vorst EPC, et al. (2024). Cellular metabolism changes in atherosclerosis and the impact of comorbidities. Front Cell Dev Biol, 12:1446964.","DOI":"10.3389\/fcell.2024.1446964"},{"key":"key-10.14336\/AD.2024.1298-131","doi-asserted-by":"crossref","unstructured":"Guo N, Chen Y, Yang X, Yan H, Fan B, Quan J, et al. (2021). Urinary metabolomic profiling reveals difference between two traditional Chinese medicine subtypes of coronary heart disease. J Chromatogr B Analyt Technol Biomed Life Sci, 1179:122808.","DOI":"10.1016\/j.jchromb.2021.122808"},{"key":"key-10.14336\/AD.2024.1298-132","doi-asserted-by":"crossref","unstructured":"Luan H, Wang X, Cai Z (2019). Mass spectrometry-based metabolomics: Targeting the crosstalk between gut microbiota and brain in neurodegenerative disorders. Mass Spectrom Rev, 38:22-33.","DOI":"10.1002\/mas.21553"},{"key":"key-10.14336\/AD.2024.1298-133","unstructured":"Chen H, Zhang L, Li Y, Meng X, Chi Y, Liu M (2024). Gut Microbiota and Its Metabolites: The Emerging Bridge Between Coronary Artery Disease and Anxiety and Depression? Aging Dis"},{"key":"key-10.14336\/AD.2024.1298-134","doi-asserted-by":"crossref","unstructured":"Pedersen ER, Tuseth N, Eussen SJ, Ueland PM, Strand E, Svingen GF, et al. (2015). Associations of plasma kynurenines with risk of acute myocardial infarction in patients with stable angina pectoris. Arterioscler Thromb Vasc Biol, 35:455-62.","DOI":"10.1161\/ATVBAHA.114.304674"},{"key":"key-10.14336\/AD.2024.1298-135","doi-asserted-by":"crossref","unstructured":"Holoch D, Moazed D (2015). RNA-mediated epigenetic regulation of gene expression. Nat Rev Genet, 16:71-84.","DOI":"10.1038\/nrg3863"},{"key":"key-10.14336\/AD.2024.1298-136","doi-asserted-by":"crossref","unstructured":"Ramazi S, Zahiri J (2021). Posttranslational modifications in proteins: resources, tools and prediction methods. Database (Oxford), 2021:","DOI":"10.1093\/database\/baab012"},{"key":"key-10.14336\/AD.2024.1298-137","doi-asserted-by":"crossref","unstructured":"Schnedl WJ, Liebminger A, Roller RE, Lipp RW, Krejs GJ (2001). Hemoglobin variants and determination of glycated hemoglobin (HbA1c). Diabetes Metab Res Rev, 17:94-8.","DOI":"10.1002\/dmrr.186"},{"key":"key-10.14336\/AD.2024.1298-138","doi-asserted-by":"crossref","unstructured":"Hong LF, Li XL, Guo YL, Luo SH, Zhu CG, Qing P, et al. (2014). Glycosylated hemoglobin A1c as a marker predicting the severity of coronary artery disease and early outcome in patients with stable angina. Lipids Health Dis, 13:89.","DOI":"10.1186\/1476-511X-13-89"},{"key":"key-10.14336\/AD.2024.1298-139","doi-asserted-by":"crossref","unstructured":"Hooshiar SH, Esmaili H, Taherian A, Jafarnejad S (2022). Exercise, Advanced Glycation End Products, and Their Effects on Cardiovascular Disorders: A Narrative Review. Heart and Mind, 6:139-150.","DOI":"10.4103\/hm.hm_31_22"},{"key":"key-10.14336\/AD.2024.1298-140","doi-asserted-by":"crossref","unstructured":"Yates JR, 3rd (2021). Rising Stars in Proteomics and Metabolomics. J Proteome Res, 20:1105-1106.","DOI":"10.1021\/acs.jproteome.0c01026"},{"key":"key-10.14336\/AD.2024.1298-141","doi-asserted-by":"crossref","unstructured":"Tziakas DN, Chalikias GK, Antonoglou CO, Veletza S, Tentes IK, Kortsaris AX, et al. (2006). Apolipoprotein E genotype and circulating interleukin-10 levels in patients with stable and unstable coronary artery disease. J Am Coll Cardiol, 48:2471-81.","DOI":"10.1016\/j.jacc.2006.08.032"},{"key":"key-10.14336\/AD.2024.1298-142","doi-asserted-by":"crossref","unstructured":"Zhang J, Long M, Yu Y (2017). The effects of additional ezetimibe treatment to baseline rosuvastatin on circulating PCSK9 among patients with stable angina. J Thorac Dis, 9:1226-1233.","DOI":"10.21037\/jtd.2017.03.186"},{"key":"key-10.14336\/AD.2024.1298-143","unstructured":"Hong LF, Yan XN, Fan Y, Wu Q, Luo SH, Yang B, et al. (2015). Is the ratio of apoB\/apoA-1 the best predictor for the severity of coronary artery lesions in Chinese diabetics with stable angina pectoris? An assessment based on Gensini scores. J Geriatr Cardiol, 12:402-9."},{"key":"key-10.14336\/AD.2024.1298-144","doi-asserted-by":"crossref","unstructured":"Van Parys A, Lysne V, Svingen GFT, Ueland PM, Dhar I, \u00d8yen J, et al. (2020). Dietary choline is related to increased risk of acute myocardial infarction in patients with stable angina pectoris. Biochimie, 173:68-75.","DOI":"10.1016\/j.biochi.2019.11.001"},{"key":"key-10.14336\/AD.2024.1298-145","doi-asserted-by":"crossref","unstructured":"Di Marino S, Viceconte N, Lembo A, Summa V, Tanzilli G, Raparelli V, et al. (2018). Early metabolic response to acute myocardial ischaemia in patients undergoing elective coronary angioplasty. Open Heart, 5:e000709.","DOI":"10.1136\/openhrt-2017-000709"},{"key":"key-10.14336\/AD.2024.1298-146","doi-asserted-by":"crossref","unstructured":"Pawlik A, Plucinska M, Kopec M, G\u0142abowski D, Czerewaty M, Safranow K (2017). MMP1 and MMP3 gene polymorphisms in patients with acute coronary syndromes. IUBMB Life, 69:850-855.","DOI":"10.1002\/iub.1684"},{"key":"key-10.14336\/AD.2024.1298-147","doi-asserted-by":"crossref","unstructured":"Tretjakovs P, Jurka A, Bormane I, Mikelsone I, Elksne K, Krievina G, et al. (2012). Circulating adhesion molecules, matrix metalloproteinase-9, plasminogen activator inhibitor-1, and myeloperoxidase in coronary artery disease patients with stable and unstable angina. Clin Chim Acta, 413:25-9.","DOI":"10.1016\/j.cca.2011.10.009"},{"key":"key-10.14336\/AD.2024.1298-148","doi-asserted-by":"crossref","unstructured":"Hung MJ, Cherng WJ, Hung MY, Kuo LT, Cheng CW, Wang CH, et al. (2012). Increased leukocyte Rho-associated coiled-coil containing protein kinase activity predicts the presence and severity of coronary vasospastic angina. Atherosclerosis, 221:521-6.","DOI":"10.1016\/j.atherosclerosis.2012.01.001"},{"key":"key-10.14336\/AD.2024.1298-149","doi-asserted-by":"crossref","unstructured":"Yoo SY, Kim J, Cheong S, Shin DH, Jang J, Lee C, et al. (2012). Rho-associated kinase 2 polymorphism in patients with vasospastic angina. Korean Circ J, 42:406-13.","DOI":"10.4070\/kcj.2012.42.6.406"},{"key":"key-10.14336\/AD.2024.1298-150","doi-asserted-by":"crossref","unstructured":"Kusama Y, Kodani E, Nakagomi A, Otsuka T, Atarashi H, Kishida H, et al. (2011). Variant angina and coronary artery spasm: the clinical spectrum, pathophysiology, and management. J Nippon Med Sch, 78:4-12.","DOI":"10.1272\/jnms.78.4"}],"container-title":["Aging and disease"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T17:37:44Z","timestamp":1733852264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aginganddisease.org\/EN\/10.14336\/AD.2024.1298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":150,"URL":"https:\/\/doi.org\/10.14336\/ad.2024.1298","relation":{},"ISSN":["2152-5250"],"issn-type":[{"value":"2152-5250","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}